.Pharmacolibrary.Drugs.B_BloodAndBloodFormingOrgans.B03X_OtherAntianemicPreparations.B03XA08_Vadadustat.Vadadustat

Information

name:Vadadustat
ATC code:B03XA08
route:oral
n-compartments2

Vadadustat is an oral hypoxia-inducible factor prolyl hydroxylase inhibitor (HIF-PHI) used to treat anemia associated with chronic kidney disease (CKD). It stimulates erythropoiesis by increasing endogenous erythropoietin levels. Vadadustat has been approved in Japan and is under regulatory review or clinical use in other countries.

Pharmacokinetics

Pharmacokinetics reported in healthy adults after single oral administration.

References

    Revisions

    Generated at 2025-07-22T18:21:06Z by OpenModelicaOpenModelica 1.25.1 using GenerateDoc.mos